Medical Marijuana

The use of marijuana and its cannabidiol (CBD) derivatives in epilepsy is a complex issue. Political leaders, medical professionals, patients and families have offered a wide variety of perspectives on this topic. The legal and regulatory issues around access to CBD change almost daily and national media have heightened attention to this issue. The following documents can be used as a resource on current information about CBD and epilepsy.

To further conversation among AES members, in AES Connect, AES is hosting a CBD interest group started by Siddharth Kapoor, M.D. 

Position Statements on Medical Marijuana

AES Press Releases on Medical Marijuana

Cannabidiol (CBD) Journal articles

Clinical Trials

There are several clinical trials with CBD happening throughout the country. To learn more about trials visit ClinicalTrials.gov.

 Other Resources

Disclaimer: AES is providing this document without representations or warranties of any kind and for information only, and it is not intended to suggest how a specific patient should receive medical treatment. Determination of whether and/or how to use all or any portion of this document is to be made in your sole and absolute discretion. No part of this document constitutes medical advice. As a clinician, your knowledge of the individual patient and judgment about what is appropriate and helpful to them should be used in making clinical decisions.